The average cost of measles cases and adverse events following vaccination in industrialised countries.

ABSTRACT:

Background

Even though the annual incidence rate of measles has dramatically decreased in industrialised countries since the implementation of universal immunisation programmes, cases continue to occur in countries where endemic measles transmission has been interrupted and in countries where adequate levels of immunisation coverage have not been maintained. The objective of this study is to develop a model to estimate the average cost per measles case and per adverse event following measles immunisation using the Netherlands (NL), the United Kingdom (UK) and Canada as examples.

Methods

Parameter estimates were based on a review of the published literature. A decision tree was built to represent the complications associated with measles cases and adverse events following imm

SUBMITTER: Carabin H 

PROVIDER: S-EPMC128813 | biostudies-literature | 2002 Sep

REPOSITORIES: biostudies-literature